Meta-analysis of problem solving therapy for the treatment of major depressive disorder in older adults

被引:62
|
作者
Kirkham, Julia G. [1 ]
Choi, Namkee [2 ]
Seitz, Dallas P. [1 ]
机构
[1] Queens Univ, Dept Psychiat, Providence Care Mental Hlth Serv, Kingston, ON K7L 3N6, Canada
[2] Univ Texas Austin, Sch Social Work, Austin, TX 78712 USA
关键词
depression; psychotherapy; psychiatry; geriatric; aged; LATE-LIFE DEPRESSION; SUPPORTIVE THERAPY; TREATMENT OUTCOMES; CARE PATIENTS; HOME-CARE; PSYCHOTHERAPY; DYSFUNCTION; DISABILITY; PREVALENCE; TRIAL;
D O I
10.1002/gps.4358
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: Major depressive disorder (MDD) affects many older adults and is associated with poor medical and mental health outcomes. Problem Solving Therapy (PST) has emerged as a promising psychotherapy for MDD in older adults, although the efficacy of PST in this population has not been well described. We examined the effectiveness of PST for the treatment of MDD in older adults in a systematic review and meta-analysis. Methods: We searched electronic databases to identify randomized controlled trials comparing PST to a control condition or other treatment for MDD in adults with an average age of 60 years or older. We used meta-analysis to arrive at pooled summary measures of the efficacy of PST when compared to control conditions on the change in depressive symptoms and other outcomes. Results: Nine studies with a total of 569 participants (290 PST, 279 control) met inclusion criteria. Most studies administered PST in person and were between 6 and 12 weeks in duration. Meta-analysis of six studies evaluating the effect of PST on depression using the Hamilton Rating Scale for Depression identified a significant reduction in depression associated with PST (pooled mean difference= -6.94, 95% CI -10.91 to -2.97, d= 1.15, P= 0.0006). PST was also effective in reducing disability in studies reporting this outcome. Conclusions: Our review supports the existing research literature on PST suggesting that it is an effective treatment for older people with MDD. Further study is required to understand long-term outcomes associated with PST and its efficacy when compared to other treatments. Copyright (C) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:526 / 535
页数:10
相关论文
共 50 条
  • [31] Treatment Rate for Major Depressive Disorder in China: a Meta-Analysis of Epidemiological Studies
    Qi, Han
    Zong, Qian-Qian
    Lok, Grace K. I.
    Rao, Wen-Wang
    An, Feng-Rong
    Ungvari, Gabor S.
    Balbuena, Lloyd
    Zhang, Qing-E
    Xiang, Yu-Tao
    [J]. PSYCHIATRIC QUARTERLY, 2019, 90 (04) : 883 - 895
  • [32] Meta-analysis of the efficacy of escitalopram and citalopram in the treatment of major depressive disorder.
    Kasper, S
    Auquier, P
    Robitail, S
    Llorca, PM
    Rive, B
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 413 - 413
  • [33] Treatment Rate for Major Depressive Disorder in China: a Meta-Analysis of Epidemiological Studies
    Han Qi
    Qian-Qian Zong
    Grace K. I. Lok
    Wen-Wang Rao
    Feng-Rong An
    Gabor S. Ungvari
    Lloyd Balbuena
    Qing-E Zhang
    Yu-Tao Xiang
    [J]. Psychiatric Quarterly, 2019, 90 : 883 - 895
  • [34] Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
    Na, Kyoung-Sae
    Lee, Kang Joon
    Lee, Ji Sung
    Cho, Young Sung
    Jung, Han-Yong
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 48 : 79 - 85
  • [35] Combination of Antidepressants in the Treatment of Major Depressive Disorder A Systematic Review and Meta-Analysis
    Rocha, Fabio Lopes
    Fuzikawa, Cintia
    Riera, Rachel
    Hara, Claudia
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (02) : 278 - 281
  • [36] Prevalence of Major Depressive Disorder Among Adults in China: A Systematic Review and Meta-Analysis
    Zhao, Yan-Jie
    Jin, Yu
    Rao, Wen-Wang
    Zhang, Qing-E
    Zhang, Ling
    Jackson, Todd
    Su, Zhao-Hui
    Xiang, Mi
    Yuan, Zhen
    Xiang, Yu-Tao
    [J]. FRONTIERS IN PSYCHIATRY, 2021, 12
  • [37] Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis
    Kishi, Taro
    Sakuma, Kenji
    Hatano, Masakazu
    Matsuda, Yuki
    Esumi, Satoru
    Miyake, Nobumi
    Miura, Itaru
    Hori, Hikaru
    Kato, Masaki
    Iwata, Nakao
    [J]. NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (01) : 216 - 220
  • [38] Intrinsic cerebral activity at resting state in adults with major depressive disorder: A meta-analysis
    Zhou, Ming
    Hu, Xinyu
    Lu, Lu
    Zhang, Lianqing
    Chen, Lizhou
    Gong, Qiyong
    Huang, Xiaoqi
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 75 : 157 - 164
  • [40] Treatment efficacy and effectiveness in adults with major depressive disorder and childhood trauma history: a systematic review and meta-analysis
    Kuzminskaite, Erika
    Gathier, Anouk W.
    Cuijpers, Pim
    Penninx, Brenda W. J. H.
    Ammerman, Robert T.
    Brakemeier, Eva-Lotta
    Bruijniks, Sanne
    Carletto, Sara
    Chakrabarty, Trisha
    Douglas, Katie
    Dunlop, Boadie W.
    Elsaesser, Moritz
    Euteneuer, Frank
    Guhn, Anne
    Handley, Elizabeth D.
    Heinonen, Erkki
    Huibers, Marcus J. H.
    Jobst, Andrea
    Johnson, Gary R.
    Klein, Daniel N.
    Kopf-Beck, Johannes
    Lemmens, Lotte
    Lu, Xiao-Wen
    Mohamed, Somaia
    Nakagawa, Atsuo
    Okada, Satoshi
    Rief, Winfried
    Tozzi, Leonardo
    Trivedi, Madhukar H.
    van Bronswijk, Suzanne
    van Oppen, Patricia
    Zisook, Sidney
    Zobel, Ingo
    Vinkers, Christiaan H.
    [J]. LANCET PSYCHIATRY, 2022, 9 (11): : 860 - 873